Related Experiment Videos
Airway remodelling in chronic lung disease of prematurity
David G Sweet1, Henry L Halliday, Jane A Warner
1Perinatal Room, Royal Maternity Hospital, Grosvenor Road, Belfast BT12 6BB, Northern Ireland, UK.
Insights
Very preterm infants often develop chronic lung disease due to early inflammation, leading to airway remodeling and respiratory issues. This "new chronic lung disease" features fewer, larger alveoli and less fibrosis.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Pediatric Critical Care
Background:
- Very preterm survivors frequently develop chronic lung disease, characterized by persistent respiratory insufficiency and need for supplemental oxygen.
- Early inflammatory responses in the lungs contribute to airway remodeling, a key feature of this condition.
- Pulmonary inflammation can stem from antenatal infection, mechanical ventilation, or oxygen toxicity.
Purpose of the Study:
- To elucidate the mechanisms underlying airway remodeling in "new chronic lung disease" in very preterm infants.
- To identify the role of inflammatory processes and neutrophil-derived enzymes in lung injury.
- To describe the pathological characteristics of this evolving form of chronic lung disease.
Main Methods:
- Review of inflammatory pathways involved in neonatal lung injury.
- Analysis of the role of neutrophil elastase and matrix metalloproteinases in extracellular matrix disruption.
- Pathological examination of lung tissue to characterize alveolar and fibrotic changes.
Main Results:
- Early inflammation triggers airway remodeling, increasing lung capillary permeability and leukocyte chemotaxis.
- Neutrophils release enzymes (elastase, matrix metalloproteinases) that degrade the lung extracellular matrix.
- The resulting "new chronic lung disease" is pathologically defined by fewer, larger alveoli and reduced pulmonary fibrosis compared to earlier forms.
Conclusions:
- Airway remodeling driven by early inflammation is central to the pathogenesis of chronic lung disease in very preterm infants.
- Neutrophil activity significantly contributes to lung extracellular matrix damage.
- This "new chronic lung disease" represents a distinct pathological entity with altered alveolar structure and fibrosis.
Abstract:
Increasing numbers of very preterm survivors are developing chronic lung disease characterised by protracted respiratory insufficiency and a requirement for supplemental oxygen. An early inflammatory response results in the development of airways remodelling. Pulmonary inflammation can be triggered by any combination of antenatal infection, mechanical ventilation or oxygen toxicity and the end result is increased lung capillary permeability and leukocyte chemotaxis. The neutrophil plays a key role in initiating lung damage by releasing enzymes such as elastase and matrix metalloproteinases that disrupt the lung extracellular matrix. The extracellular matrix is essential for the normal alignment and differentiation of pneumocytes and pulmonary capillaries. This so called "new chronic lung disease" resulting from airways remodelling and arrested lung development is characterised pathologically by fewer, larger alveoli and less pulmonary fibrosis than previously described.